Literature DB >> 12672261

Treatment of aggression in children and adolescents with autism and conduct disorder.

Christopher J McDougle1, Kimberly A Stigler, David J Posey.   

Abstract

The optimal clinical management of aggression in children and adolescents involves both behavioral and pharmacologic intervention strategies. This article reviews medication treatments for youngsters with autistic disorder and conduct disorder, conditions for which the pharmacologic management of aggression is often necessary. Efficacy results and associated adverse effects from selected clinical trials of most classes of psychotropic medications are discussed. While preliminary progress has been made in the development of medication treatments for these serious disorders of youth, additional controlled research and longitudinal studies are needed to better understand the efficacy and tolerability of currently available compounds within each diagnostic group.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672261

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  17 in total

Review 1.  Psychotropic medications in autism: practical considerations for parents.

Authors:  Edwin D Williamson; Andres Martin
Journal:  J Autism Dev Disord       Date:  2012-06

2.  Rates of Co-occurring Psychiatric Disorders in Autism Spectrum Disorder Using the Mini International Neuropsychiatric Interview.

Authors:  Maya G Mosner; Jessica L Kinard; Jasmine S Shah; Sean McWeeny; Rachel K Greene; Sarah C Lowery; Carla A Mazefsky; Gabriel S Dichter
Journal:  J Autism Dev Disord       Date:  2019-09

Review 3.  Pharmacological aspects of the treatment of conduct disorder in children and adolescents.

Authors:  Oleg V Tcheremissine; Lori M Lieving
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 4.  Epilepsy in autism spectrum disorders.

Authors:  Roberto Canitano
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-24       Impact factor: 4.785

5.  Long-Term Aripiprazole in Youth With Developmental Disabilities Including Autism.

Authors:  Jessica A Hellings; Danna Boehm; Hung Wen Yeh; Merlin G Butler; Stephen R Schroeder
Journal:  J Ment Health Res Intellect Disabil       Date:  2011-03-07

6.  The Treatment of Anxiety in Autism Spectrum Disorder (TAASD) Study: Rationale, Design and Methods.

Authors:  Connor M Kerns; Jeffrey J Wood; Philip C Kendall; Patricia Renno; Erika A Crawford; Rogelio J Mercado; Cori Fujii; Amanda Collier; Alexandra Hoff; Elana R Kagan; Brent J Small; Adam B Lewin; Eric A Storch
Journal:  J Child Fam Stud       Date:  2016-02-06

7.  Reduction of Aggressive Episodes After Repeated Transdermal Nicotine Administration in a Hospitalized Adolescent with Autism Spectrum Disorder.

Authors:  Gerrit I Van Schalkwyk; Alan S Lewis; Zheala Qayyum; Kourtney Koslosky; Marina R Picciotto; Fred R Volkmar
Journal:  J Autism Dev Disord       Date:  2015-09

8.  Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study.

Authors:  Justine M Kent; Stuart Kushner; Xiaoping Ning; Keith Karcher; Seth Ness; Michael Aman; Jaskaran Singh; David Hough
Journal:  J Autism Dev Disord       Date:  2013-08

Review 9.  Antipsychotics in the treatment of autism.

Authors:  David J Posey; Kimberly A Stigler; Craig A Erickson; Christopher J McDougle
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 10.  Intervention for autistic spectrum disorders.

Authors:  Pauline A Filipek; Robin Steinberg-Epstein; Teri M Book
Journal:  NeuroRx       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.